Скачать с ютуб AI4Proteins: General Effects of AI on Drug Discovery - Dr Derek Lowe в хорошем качестве

AI4Proteins: General Effects of AI on Drug Discovery - Dr Derek Lowe

This seminar forms part of the AI3SD and RSC-CICAG AI4Proteins Series. This series is sponsored by Arctoris and Schrödinger. This video is the thirteenth talk in the Protein Structure Prediction Conference. General Effects of AI on Drug Discovery - Dr Derek Lowe Abstract: The advent of gradually more effective AI/ML techniques is already having effects on the traditional practices of medicinal chemistry and drug discovery in general. What can we expect as the process goes on, and how will drug discovery scientists have to adjust their thinking and their research roles? Bio: I’ve been working in biopharma drug discovery since 1989 in a variety of therapeutic areas, and in recent years I’ve focused more on chemical biology. I’m currently a director with the Novartis (NIBR) Chemical Biology and Therapeutics organization. I’m also known for my web site, “In the Pipeline”, hosted at Science Translational Medicine, which is (I believe) now the oldest/longest-running science blog on the internet (since 2002). Further details from this series can be found at: https://www.ai3sd.org/ai4proteins This video is an output from the AI3SD Network+ (Artificial Intelligence and Augmented Intelligence for Automated Investigations for Scientific Discovery) which is funded by EPSRC under Grant Number EP/S000356/1 DOI Link: http://dx.doi.org/10.5258/SOTON/P0106